Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 24 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Parkinson Disease [Clear All Filters]
The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients..
Neurol Sci. 40(4), 683-690.
(2019). Exergames for Parkinson's Disease Patients: How Participatory Design Led to Technology Adaptation..
Stud Health Technol Inform. 251, 78-81.
(2018).
(2018). CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes..
J Neurol Sci. 382, 91-95.
(2017). Treatment of a female patient with persistent genital arousal and Parkinson's disease with paliperidone..
Aust N Z J Psychiatry. 51(1), 98-99.
(2017).
(2016).
Assessment of Parkinson's disease risk loci in Greece..
Neurobiol Aging. 35(2), 442.e9-442.e16.
(2014). Genetic assessment of familial and early-onset Parkinson's disease in a Greek population..
Eur J Neurol. 21(7), 963-8.
(2014). Helicobacter pylori infection and Parkinson's disease: apoptosis as an underlying common contributor..
Eur J Neurol. 19(6), e56.
(2012). Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population..
Genet Test Mol Biomarkers. 16(8), 974-7.
(2012). Lack of association of the PICALM rs3851179 polymorphism with Parkinson's disease in the Greek population..
Int J Neurosci. 122(10), 502-605.
(2012). Pupillometry and 123I-DaTSCAN imaging in Parkinson's disease: a comparison study..
Int J Neurosci. 122(1), 26-34.
(2012).
(2012). Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population..
J Clin Neurosci. 18(12), 1744-5.
(2011). Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study..
Lancet Neurol. 10(10), 898-908.
(2011). Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease..
Int J Clin Pract. 65(12), 1289-94.
(2011). Pupil light reflex in Parkinson's disease: evaluation with pupillometry..
Int J Neurosci. 121(1), 37-43.
(2011). Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial..
Lancet Neurol. 9(10), 969-77.
(2010). Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study..
Int J Neurosci. 120(11), 724-30.
(2010). Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece..
Neurosci Lett. 452(2), 87-9.
(2009). MEG evaluation of Parkinson's diseased patients after external magnetic stimulation..
Acta Neurol Belg. 107(1), 5-10.
(2007). Association of the Tau haplotype with Parkinson's disease in the Greek population..
Mov Disord. 21(7), 1036-9.
(2006). [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor]..
Hell J Nucl Med. 8(2), 81-5.
(2005). Low-frequency MEG activity and MRI evaluation in Parkinson's disease..
Brain Topogr. 18(1), 59-63.
(2005).